GB790762A - A hydrate of lignocaine hydrochloride and process for making it - Google Patents
A hydrate of lignocaine hydrochloride and process for making itInfo
- Publication number
- GB790762A GB790762A GB2388853A GB2388853A GB790762A GB 790762 A GB790762 A GB 790762A GB 2388853 A GB2388853 A GB 2388853A GB 2388853 A GB2388853 A GB 2388853A GB 790762 A GB790762 A GB 790762A
- Authority
- GB
- United Kingdom
- Prior art keywords
- hydrochloride
- monohydrate
- lignocaine
- water
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention comprises diethylaminoacetyl-2:6 - dimethylanilide ("lignocaine") hydrochloride monohydrate in the form of discrete particles and processes for its manufacture by combining lignocaine hydrochloride with sufficient water to form the monohydrate. The manufacture may suitably be carried out by precipitating the monohydrate from an aqueous solution of the hydrochloride by adding a water-miscible organic solvent, or by crystallizing the monohydrate from a solution of the hydrochloride in a solvent consisting of a mixture of water and a water-miscible liquid (e.g. acetone, methyl ethyl ketone or dioxane), or by bringing the hydrochloride into contact with water vapour, e.g. by treating it with humid air, until the hydrochloride has taken up sufficient water to form the monohydrate and which is then recrystallized from a solvent in order to form discrete particles. In examples: (1) lignocaine is dissolved in 33 per cent hydrochloric acid, acetone is added and the monohydrate is crystallized from the solution; (2) lignocaine hydrochloride formed by subjecting a solution of lignocaine in dilute hydrochloric acid to azeotropic distillation with benzene is recrystallized from methyl ethyl ketone containing a small quantity of water, to give the monohydrate and (3) lignocaine hydrochloride is exposed to humid air and the resulting hydrate is recrystallized from methyl ethyl ketone.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2388853A GB790762A (en) | 1953-08-28 | 1953-08-28 | A hydrate of lignocaine hydrochloride and process for making it |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2388853A GB790762A (en) | 1953-08-28 | 1953-08-28 | A hydrate of lignocaine hydrochloride and process for making it |
Publications (1)
Publication Number | Publication Date |
---|---|
GB790762A true GB790762A (en) | 1958-02-19 |
Family
ID=10202948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2388853A Expired GB790762A (en) | 1953-08-28 | 1953-08-28 | A hydrate of lignocaine hydrochloride and process for making it |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB790762A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004006894A1 (en) * | 2002-07-16 | 2004-01-22 | Bayer Healthcare Ag | Medicaments containing vardenafil hydrochloride trihydrate |
EP1891010A2 (en) | 2005-06-17 | 2008-02-27 | L. Molteni & C. Dei Fratelli Alitti Societa' Di Esercizio S.P.A | A process for the preparation of an injectable solution of (2s)-n-(2;6-dimethyl-phenyl)-1-propyl-2-piperidincarboxamide |
US8613950B2 (en) | 2005-03-01 | 2013-12-24 | Bayer Intellectual Property Gmbh | Pharmaceutical forms with improved pharmacokinetic properties |
CN114524749A (en) * | 2022-03-01 | 2022-05-24 | 遂成药业股份有限公司 | N-diethyl acetyl-2, 6-dimethylaniline crystal and preparation method thereof |
-
1953
- 1953-08-28 GB GB2388853A patent/GB790762A/en not_active Expired
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004006894A1 (en) * | 2002-07-16 | 2004-01-22 | Bayer Healthcare Ag | Medicaments containing vardenafil hydrochloride trihydrate |
AU2003249942B2 (en) * | 2002-07-16 | 2009-10-29 | Bayer Intellectual Property Gmbh | Medicaments containing vardenafil hydrochloride trihydrate |
CN1681481B (en) * | 2002-07-16 | 2010-12-15 | 拜耳先灵制药股份公司 | Medicaments containing vardenafil hydrochloride trihydrate |
EP2272505A1 (en) * | 2002-07-16 | 2011-01-12 | Bayer Schering Pharma AG | Pharmaceutical compositions containing vardenafil hydrochloride trihydrate |
US8273876B2 (en) | 2002-07-16 | 2012-09-25 | Bayer Intellectual Property Gmbh | Medicaments containing vardenafil hydrochloride trihydrate |
HRP20050143B1 (en) * | 2002-07-16 | 2014-01-31 | Bayer Intellectual Property Gmbh | Medicaments containing vardenafil hydrochloride trihydrate |
CN102210689B (en) * | 2002-07-16 | 2014-07-30 | 拜耳知识产权有限责任公司 | Medicaments containing vardenafil hydrochloride trihydrate |
EP2272505B1 (en) | 2002-07-16 | 2016-10-12 | Bayer Intellectual Property GmbH | Tablets containing vardenafil hydrochloride trihydrate |
HRP20120418B1 (en) * | 2002-07-16 | 2018-01-26 | Bayer Intellectual Property Gmbh | Pharmaceutical compositions containing vardenafil hydrochloride trihydrate |
US8613950B2 (en) | 2005-03-01 | 2013-12-24 | Bayer Intellectual Property Gmbh | Pharmaceutical forms with improved pharmacokinetic properties |
EP1891010A2 (en) | 2005-06-17 | 2008-02-27 | L. Molteni & C. Dei Fratelli Alitti Societa' Di Esercizio S.P.A | A process for the preparation of an injectable solution of (2s)-n-(2;6-dimethyl-phenyl)-1-propyl-2-piperidincarboxamide |
CN114524749A (en) * | 2022-03-01 | 2022-05-24 | 遂成药业股份有限公司 | N-diethyl acetyl-2, 6-dimethylaniline crystal and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB790762A (en) | A hydrate of lignocaine hydrochloride and process for making it | |
Herbst et al. | The nitration of 5-aminotetrazole | |
CH423747A (en) | Process for the continuous crystallization of adipic acid from its solutions | |
GB761093A (en) | Production of s-acetyl glutathione | |
Bell et al. | The preparation and properties of the perchlorates of some choline esters | |
US3297760A (en) | Para amino-nu-ethyl-nu-beta-hydroxy-ethyl-meta toluidine mono-nitrate and di-nitrate nd methods of producing same | |
US2768875A (en) | Stabilizing aqueous solutions of polythionates and polythionic acids | |
US3138545A (en) | Dehydration of nu, nu-dimethylhydrazine by distillation in the presence of an alkali | |
US2517760A (en) | 2-(p-isothiocyanobenzenesulfonamido)-pyrimidine | |
GB760027A (en) | Improved bis(beta-hydroxyethyl) terephthalate | |
DE915566C (en) | Process for the preparation of N-acylated amino sugars | |
GB668994A (en) | Process for the purification of adrenalin | |
GB695504A (en) | Method of isolating and purifying cholic and desoxycholic acids | |
GB954841A (en) | A method for the preparation of a stable crystalline form of 1-(5-nitrofurfurylideneamino)-hydantoin | |
GB711307A (en) | Improvements in or relating to a new derivative of ª -pyridine aldehyde | |
GB723636A (en) | Dichloracetoxy-p-nitrophenyl-amino-propanol salts and process for the manufacture thereof | |
GB707337A (en) | Manufacture of 1.4-dihydrazinophthalazines | |
GB770263A (en) | Process for the manufacture of acetoacetamides | |
GB739156A (en) | Improvements in or relating to treatment of benzene hexachloride | |
GB733268A (en) | Improvements in or relating to process for purification of tyrosine | |
FR740524A (en) | Process for the purification of trinitrotoluene | |
GB809117A (en) | Improved process for preparing aromatic aldehyde-carboxylic acids | |
Gardner et al. | Structures of 4-Nitro-and 5-Nitro-2-propionulpyrroles | |
GB682280A (en) | Purification of ortho-methoxyphenylacetone | |
GB658766A (en) | Improvements in and relating to the purification of antibiotics |